{
  "study_metadata": {
    "study_id": null,
    "design": "RCT"
  },
  "exposure": {
    "label": "resveratrol",
    "comparator": "placebo"
  },
  "outcomes": [],
  "comment_detailed": "The article describes a 30‑day randomized, placebo‑controlled trial of resveratrol in obese humans, but it does not report numeric values for glycaemic indices such as fasting plasma glucose, HbA1c or HOMA‑IR. Only that blood samples were taken for glucose and insulin measurement is mentioned. Consequently, no outcome data can be extracted.",
  "missing_fields": [
    "study_metadata.study_id",
    "outcomes"
  ],
  "evidence": [
    "\"30 days of resveratrol supplementation\"",
    "\"placebo\"",
    "\"blood samples were withdrawn for the determination of plasma glucose, insulin\""
  ],
  "comment": "Insufficient data for glycemic outcomes",
  "confidence": 0.4
}